## LII: Lennox International, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.6% below STRENGTH zone (3.0-6.0%); PEG 1.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($457.03)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. BLI Banque de Luxembourg Investments Trims Position in Lennox International, Inc. $LII**
- Source: MarketBeat | 20251130T105113 | Neutral | Relevance: 98%
- BLI Banque de Luxembourg Investments significantly reduced its stake in Lennox International, Inc. (NYSE:LII) by 11.0% in the second quarter, selling 2,700 shares and holding 21,800 shares valued at $12,368,000. Other institutional investors showed mixed activity, with some increasing and others decreasing their positions in LII. The article also details insider transactions, stock performance metrics, dividend information, and recent analyst ratings for Lennox International.

**2. Subdued Growth No Barrier To Lennox International Inc.'s (NYSE:LII) Price**
- Source: 富途牛牛 | 20251202T190400 | Neutral | Relevance: 98%
-  Lennox International Inc. (NYSE:LII) has a price-to-earnings (P/E) ratio of 20.4x, similar to the US market median of 19x, despite analysts forecasting weaker earnings growth of 2.9% for the coming year compared to the market's 16% prediction. While the company has shown decent historical earnings growth, its current P/E suggests investors are overlooking the subdued growth outlook. This situation could make it challenging for the stock to maintain its current price levels unless growth expectations improve.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Wells Fargo | $525 | $545 | -4% |
| 2025-11-13 | Wolfe Research | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Wells Fargo | main | Equal-Weight |
| 2025-11-13 | Wolfe Research | up | Peer Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.19M) |
| Sells | 8 ($2.36M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 8.6% (+0.7%)
- Capital Internationa: 4.2% (-4.7%)
- State Street Corpora: 4.1% (+2.3%)
- Morgan Stanley: 3.8% (-5.6%)

### Key Risks

1. Long-term trend broken: trading 12.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.63 elevated, pricing in significant growth expectations. Forward P/E 19.5x stretched relative to 9% growth. Quality metrics strong (ROE 92%, ROA 19%, margin 16%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.4M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $17.8B |
| Beta | 1.16 |
| 52W Range | $443.19 - $689.44 |
| Short Interest | 6.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.63 |
| Forward P/E | 19.5 |
| Current P/E | 21.2 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.8% to 0.6% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.4pp (needs >3.0% for momentum thesis). MRS_5 (-1.3%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram positive (5.09), confirming momentum. RSI neutral at 50.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.59% (CS: 73) | Neutral |
| RSI_14 | 50.1 | Neutral |
| MACD Histogram | 5.09 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 0.966x | Below |
| vs SMA200 | 0.871x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $487.29
- **Stop Loss:** $457.03 (6.2% risk)
- **Target:** $517.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 16
- **Position Value:** $7,796.64
- **Portfolio %:** 7.80%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $4.76)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.84 | $6.98 | +2.0% |
| 2025Q2 | $6.87 | $7.82 | +13.9% |
| 2025Q1 | $3.25 | $3.37 | +3.6% |
| 2024Q4 | $4.24 | $5.60 | +32.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*